上海招聘

Job Responsibilities:
? Making arrangement for Investigator Meetings & Study Team Meetings including taking minutes.
安排和协调研究者会议及项目组会议事务，包括会议记录等.
? Assist with the Ethics / Regulatory Submissions and keep a track of submissions & approvals for the study.
协助伦理和法规的递交工作，跟踪递交与批复的记录
? Preparing copies of Protocols, Investigator Brochures and CRFs which includes keeping track and re-ordering supplies.
准备研究方案，研究者手册和病例报告表,跟踪物资的申请、发放与保存记录
? Setting up and maintenance of the Trial Master Files (TMF) or Electronic filing systems/ set up of the Investigator Site File (IF)
建立并管理试验主文件夹及电子文档保存系统，协助研究者文件夹的设立
? Preparing essential clinical trial documentation, distributing, tracking and filing of documents on return.
准备试验基础文件的相关记录，发放、跟踪与回收事务
? Create & maintain study contact lists for team/sites/3rd parties etc.
建立和更新试验联系通讯录，包括团队，中心和第三方供应商的。
? Sending out Study Newsletters / Study Correspondence to all participating sites on an ongoing basis
向所有研究中心发放试验通讯及研究相关信息
? Setting up of finance systems accurately, processing invoices & tracking payments for the trial for investigator payments.
准确建立试验相关财务管理体系，包括跟踪开票，付款给研究者等等。
? Assist with collating, tracking & shipping CRFs & data queries to Data Management.
协助数据管理部门收集及跟踪CRF及数据疑问
? General study filing, including uploading of documents into global repository.
日常收集试验整体信息，按要求上传或发送至总部文档数据库
? Assisting Clinical Research Associates on monitoring visits i.e. file reconciliation.
协助CRA的例行监查相关工作例如文件核对工作
? Re-ordering clinical drug supplies for sites, arranging for trial drug destructions with external vendors.
申购及后续申购试验药物相关的各中心配送及管理，试验后安排外部供应商进行销毁。

CStone Pharmaceuticals is an innovative, research-based, biopharmaceutical company committed to the development of a new generation of therapeutic drugs. Based in both Shanghai and Suzhou, the company's leadership team consists of seasoned executives from top pharmaceutical MNCs. In July 2016, CStone announced the completion of its Series A financing, raising a total of US$150 million (about 975 million RMB). Three prestigious investment companies in the industry, Oriza Seed Venture Capital (Oriza Seed), Boyu Capital, and WuXi Healthcare Ventures (WXHV), jointly invested in the round. With an overarching commitment to meeting the most pressing needs of Chinese patients, the company's pipeline covers five therapeutic areas, including oncology, cardiovascular diseases, rheumatoid arthritis, hematology and autoimmune diseases. With immuno-oncology as CStone's core therapeutic focus, the company strives to lead Chinese research to the global market through its world class R&D team, its innovative portfolio, and an open innovation strategy.
基石药业是一家创新的研发驱动型生物制药公司，致力于开发新一代的治疗性药物，创立于中国上海和苏州两地，公司的领导团队由来自国际***药企的管理层成员组成。 2016年7月宣布完成A轮融资，共募集到1.5亿美元（约9.75亿人民币）资金，由三家颇具声望的投资公司参与，分别是元禾原点创业投资管理有限公司、博裕资本及毓承资本。
目前，基石药业拥有肿瘤、心血管、风湿性关节炎、血液病及自身免疫病等五个治疗领域的产品线，旨在满足中国病患重大迫切的临床需求。在广受瞩目的肿瘤治疗领域，基石药业以其出色的肿瘤免疫药物为核心，凭借其世界级的研发团队，最前沿的药物研发项目，以及开放式创新的策略有望引领国内新药研发行业走向全球。